With healthcare rapidly evolving through digital transformation, the demand for smarter, more efficient solutions is rising, ...

“The data from the PRISM clinical trial ... development and have not yet been approved for marketing by the FDA or any other regulatory authority. No representation is made as to the safety ...

D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...

Prism is a groundbreaking psychometric assessment that measures ... at 20:00 Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related ...

On 29 January, SPIE, the international society for optics and photonics, recognized the top-rated new optics and photonics products with the industry-focused Prism Awards. The gala evening ...

All of our product candidates are in clinical or preclinical development and have not yet been approved for marketing by the FDA or any other regulatory authority. No representation is made as to ...

Yesterday, we were excited to announce the signing to acquire a controlling interest in PRISM Vision, which is a provider of general ... development of 33 of the 47 therapies approved by the FDA.

Welcome to McKesson's Third Quarter Fiscal 2025 Earnings Conference Call. Please be advised that today's conference is being recorded. At this time, I'd like to turn the conference over to Rachel ...

Assessments of healthy weight loss, or fat loss with lean mass preservation, are consistent with recently issued FDA draft guidance on developing ... Wave’s RNA medicines platform, PRISM ®, combines ...

The Advertising Regulatory Council of Nigeria, ARCON, has been in the news recently over the N1 million violation fee it ...

WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA - a genetically validated target that provides a new approach for healthy, sustainable weight loss (fat loss with muscle preservation) ...